InsidersTradesSigma
Browse the detailed record of transactions filed by Bellemin Jean-Marc, 首席财务官. Director active across 1 company, notably Iovance Biotherapeutics, INC.. In total, 1 disclosures have been published. Activity tracked since 14 June 2022. The latest transaction was filed on 14 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Jean-Marc Bellemin serves as Chief Financial Officer at IOVANCE BIOTHERAPEUTICS, INC. In this role, he oversees the company's financial management, including financial planning and regulatory compliance. Jean-Marc plays a key role in optimizing financial resources and in strategic decision-making to support the company's growth.